Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Thursday, February 13, 2020
PHASTAR announced the company has chosen San Diego as the site for its new U.S. west coast office, which will be led by Dr. LaRee Tracy, PhD, as Director of Biostatistics.
read more
Phastar, a global biometrics contract research organization (CRO), announced it is offering pro bono support to Medicines Development for Global Health (MDGH), a not-for-profit organization developing medicines for neglected diseases primarily ...
read more
PHASTAR, a global specialist biometrics contract research organization (CRO) offering industry leading data management, data science, statistical consulting, and clinical trial reporting services, announces that Chris Schoonmaker has joined the ...
read more
Wednesday, August 04, 2021
PHASTAR, a specialist biometrics contract research organization offering industry-leading data management, data science, statistical consulting and clinical trial reporting services, announced the appointment of Chuck Gelb as Chief Commercial Officer...
read more
Monday, December 05, 2022
PHASTAR has announced the launch of a pro-bono scheme to give charities access to its volunteer statisticians, data scientists, data managers and programmers at no cost.
read more
Thursday, December 15, 2022
PHASTAR, a global specialist biometrics contract research organization (CRO), has joined Lean Life Science’s Oncology Development Programme (ODP2).
read more
Thursday, August 10, 2023
Phastar announced the appointment of Graham Clark as the new Chief Executive Officer. Amid ambitious growth plans and organizational changes, Clark will succeed Andrew MacGarvey as CEO and further boost the paradigm shift in delivery of world-class ...
read more
Phastar announced the appointment of Billy Amzal as Head of Strategic Consulting. Amzal is a statistician, public health scientist, and entrepreneur with more than 25 years of experience across biotech and pharmaceutical industries, health agencies, ...
read more
Thursday, August 15, 2019
PHASTAR announced Jennifer Rogers, PhD, has been appointed Head of Statistical Research.
read more
Thursday, September 26, 2024
Phastar has been named as a finalist for the Best Contract Research Organization - Specialist Providers category at the 2024 Scrip Awards. Phastar was recognized for its Clinical Intelligence Portal, a high-quality data analytics, visualization, and ...
read more
PhaseBio announced a financing and co-development collaboration with SFJ Pharmaceuticals to support the development of PB2452, a reversal agent for the antiplatelet therapy ticagrelor.
read more
PharPoint Research, a U.S.-based contract research organization (CRO), has announced the expansion of their clinical trial management and consulting service capabilities into Europe.
read more
Tuesday, November 03, 2015
PharPoint Research, Inc., a contract research organization (CRO), has announced that the stable growth of new employees has led to the expansion of their Wilmington, NC office.
read more
Wednesday, December 11, 2013
PharmSource, the acknowledged authority on bio/pharmaceutical contract manufacturing, has released an extensive
study on the supply and demand for contract injectable manufacturing through 2019. This important analysis
provides invaluable ...
read more
PharmScript announced the acquisition of Rx Med, a long-term care pharmacy located near Nashville, Tennessee.
read more